Metformin Export Market Intelligence: India's 528 Suppliers Shipping to 160 Countries — TransData Nexus 2026

Q: Who are the top metformin exporters from India?

The top metformin exporters from India are: 1. GRANULES INDIA LIMITED — $152.5M (32.7% market share); 2. MEDEOR LIFE CARE LLP — $45.1M (9.7% market share); 3. INVENTIA HEALTHCARE LIMITED — $23.1M (5.0% market share); 4. IPCA LABORATORIES LIMITED — $20.7M (4.4% market share); 5. ZENTIVA PRIVATE LIMITED — $19.4M (4.2% market share). Together they account for 55.9% of India's total metformin export value.

Q: What is the total export value of metformin from India?

The total export value of metformin from India is $466.4M USD, recorded across 15,000 shipment transactions from 528 active exporters to 160 destination countries. The average shipment value is $31.1K.

Q: Which countries import metformin from India?

India exports metformin to 160 countries worldwide. The top importing countries are: UNITED STATES (36.7% share, $171.1M), GEORGIA (9.7% share, $45.3M), FRANCE (4.9% share, $22.8M), UNITED KINGDOM (4.4% share, $20.5M), BELGIUM (3.6% share, $16.9M). These five markets account for 59.3% of total export value.

Q: What is the HS code for metformin exports from India?

The primary HS code for metformin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of metformin exports from India?

The average unit price for metformin exports from India is $60.65 USD per unit, with prices ranging from $0.00 to $21062.67 depending on formulation, packaging, and order volume. The total market is valued at $466.4M across 15,000 shipments.

Q: Which ports handle metformin exports from India?

The primary ports for metformin exports from India are NHAVA SHEVA SEA (INNSA1) (15.2% of shipments), SAHAR AIR CARGO ACC (INBOM4) (10.9% of shipments), HYDERABAD ICD (INSNF6) (10.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (9.0% of shipments), SAHAR AIR (6.8% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of metformin?

India is one of the world's leading exporters of metformin due to its large base of 528 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports metformin to 160 countries, demonstrating 82% global market coverage.

Q: What certifications do Indian metformin exporters need?

Indian metformin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import metformin from India?

There are 1,475 registered buyers importing metformin from India, spread across 160 countries. The repeat buyer rate is 63.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top metformin supplier from India?

GRANULES INDIA LIMITED is the leading metformin exporter from India with a market share of 32.7% and total export value of $152.5M across 2278 shipments. The top 5 suppliers together control 55.9% of total export value.

Suresh Sormare

Metformin

India Pharmaceutical Trade Intelligence

$466.4M528 Suppliers160 CountriesHS 30049099

ExportsIndia → UNITED STATES36.7%India → GEORGIA9.7%

ImportsGREECE → India$37.7B GERMANY → India$15.6M

#1 Supplier: GRANULES INDIA

Metformin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Metformin to the World

Between 2022 and 2026, India exported $466.4M worth of metformin across 15,000 verified shipments to 160 countries — covering 82% of world markets in the Diabetes & Endocrine segment. The largest destination is UNITED STATES (36.7%). GRANULES INDIA LIMITED leads with a 32.7% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published May 2026·Updated May 2026·

Metformin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Metformin export data snapshot — $466.4M · 528 exporters · 160 countriesTransData Nexus · Indian Customs Data

Top Metformin Exporters from India

528 active exporters · Ranked by export value

View all 528 →

Top Metformin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	GRANULES INDIA LIMITED	$152.5M	2,278	19	32.7%
2	MEDEOR LIFE CARE LLP

Top Countries Importing Metformin from India

160 destination markets · Ranked by import value

All 160 countries →

Top Countries Importing Metformin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$171.1M	36.7%
2	GEORGIA	$45.3M	9.7%
3	FRANCE	$22.8M	4.9%
4	UNITED KINGDOM	$20.5M	4.4%
5	BELGIUM	$16.9M	3.6%
6	SOUTH AFRICA	$15.0M	3.2%
7	MALTA	$14.8M	3.2%
8	PHILIPPINES	$13.4M	2.9%
9	CANADA	$12.2M	2.6%
10	GERMANY	$10.0M	2.1%

UNITED STATES is India's largest metformin export destination, absorbing 36.7% of total exports worth $171.1M. The top 5 importing countries — UNITED STATES, GEORGIA, FRANCE, UNITED KINGDOM, BELGIUM — together account for 59.3% of India's total metformin export value. The remaining 155 destination countries collectively receive the other 40.7%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Metformin to India?

52 origin countries · Total import value: $2150.0B

India imports metformin from 52 countries with a combined import value of $2150.0B. The largest supplier is TURKEY ($2110.6B, 255 shipments), followed by GREECE and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Metformin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	TURKEY	$2110.6B	255	98.2%
2	GREECE	$37.7B	100	1.8%
3	UNITED STATES	$1.6B	525	0.1%
4	SPAIN	$111.2M	41	0.0%
5	GERMANY	$15.6M	125	0.0%
6	SINGAPORE	$9.5M	215	0.0%
7	CANADA	$1.2M	107	0.0%
8	SWITZERLAND	$889.7K	16	0.0%
9	PUERTO RICO	$321.9K	8	0.0%
10	MALAYSIA	$247.6K	29	0.0%

Showing top 10 of 52 origin countries

TURKEY is the largest supplier of metformin to India, accounting for 98.2% of total import value. The top 5 origin countries — TURKEY, GREECE, UNITED STATES, SPAIN, GERMANY — together supply 100.0% of India's metformin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Metformin — Export Intelligence Video

Visual overview of India's metformin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's metformin pharmaceutical import and export market — $466.4M in total trade, 528 verified manufacturers, and 160 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Metformin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, metformin is approved through Abbreviated New Drug Applications (ANDAs), allowing generic manufacturers to market the drug upon demonstrating bioequivalence to the reference listed drug. The FDA's Orange Book lists numerous approved ANDAs for metformin, reflecting its established presence in the market. Recent approvals include [specific approval dates and numbers, if available]. Importantly, there are no current FDA import alerts for metformin, indicating compliance with regulatory standards. The substantial number of Indian exporters—528 active between 2022 and 2026—underscores India's significant role in supplying metformin to the U.S. market.

2EU & UK Regulatory Framework

In the European Union, metformin requires marketing authorization from the European Medicines Agency (EMA) or national competent authorities. The EMA's centralized procedure facilitates approval across member states, ensuring consistent quality, safety, and efficacy standards. Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for manufacturers. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the authorization and regulation of metformin, adhering to stringent GMP requirements. The presence of Indian exporters in these markets highlights the importance of maintaining compliance with EU and UK regulatory standards.

3WHO Essential Medicines & Global Standards

Metformin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in managing diabetes globally. The 24th edition of the list, published in September 2025, continues to feature metformin as a fundamental treatment option. Additionally, metformin is listed in the International Pharmacopoeia, which provides quality specifications for essential medicines, ensuring consistency in manufacturing and quality control processes worldwide. (who.int)

4India Regulatory Classification

In India, metformin is classified as a Schedule H drug under the Drugs and Cosmetics Act, requiring a prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) regulates its price to ensure affordability; the latest ceiling price was set in [specific month and year]. For export purposes, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and to monitor the quality of pharmaceutical exports.

5Patent & Exclusivity Status

Metformin's primary patents have long expired, leading to a competitive generic market. This has facilitated the entry of multiple manufacturers, including numerous Indian exporters, contributing to its widespread availability and affordability globally.

6Recent Industry Developments

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the Model List of Essential Medicines, reaffirming metformin's inclusion due to its efficacy and safety profile. (who.int) In September 2025, the WHO published the 24th edition of the Model List of Essential Medicines, continuing to feature metformin as a fundamental treatment option. (who.int)

These developments reflect the ongoing recognition of metformin's importance in global health and the pharmaceutical industry's commitment to maintaining its availability and quality.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Metformin

Retail & reference prices across 9 markets vs. India FOB export price of $60.65/unit

Global Price Benchmark for Metformin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.10	USD	According to the FDA's Orange Book, multiple generic versions of Metformin 500 mg tablets are approved, contributing to competitive pricing in the U.S. market.
United Kingdom	$0.07	GBP	The NHS Drug Tariff lists Metformin 500 mg tablets, ensuring standardized pricing across the UK healthcare system.
Germany	$0.09	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceutical pricing, including Metformin, to maintain affordability.
Australia

Supply Chain Risk Assessment — Metformin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, often referred to as the "pharmacy of the world," heavily relies on China for Key Starting Materials (KSMs) essential in Active Pharmaceutical Ingredient (API) production. Approximately 70% of India's APIs are sourced from China, underscoring a significant dependency. This reliance exposes the supply chain to vulnerabilities, as disruptions in Chinese manufacturing—due to environmental regulations, geopolitical tensions, or other factors—can lead to shortages and increased costs for Indian manufacturers.

In response, the Indian government launched the Production Linked Incentive (PLI) scheme in 2024, aiming to bolster domestic API and KSM production. By November 2024, two greenfield plants were inaugurated under this initiative to manufacture critical molecules like Penicillin G and Clavulanic Acid, which had not been produced domestically for over two decades. Despite these efforts, challenges such as higher production costs and infrastructure limitations persist, making it difficult for India to achieve self-sufficiency in API production.

2Supplier Concentration & Single-Source Risk

Analysis of TransData Nexus's proprietary trade data from 2022 to 2026 reveals that the top five Indian exporters account for 55.9% of Metformin exports, with GRANULES INDIA LIMITED alone contributing 32.7% ($152.5M USD). This high supplier concentration poses a significant risk; any operational disruptions within these key companies could severely impact global Metformin supply.

Access Complete Metformin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 15,000 transactions across 160 markets.

Request Demo View Pricing

Frequently Asked Questions — Metformin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top metformin exporters from India?

The leading metformin exporters from India are GRANULES INDIA LIMITED, MEDEOR LIFE CARE LLP, INVENTIA HEALTHCARE LIMITED, and 12 others. GRANULES INDIA LIMITED leads with 32.7% market share ($152.5M). The top 5 suppliers together control 55.9% of total export value.

What is the total export value of metformin from India?

The total export value of metformin from India is $466.4M, recorded across 15,000 shipments from 528 active exporters to 160 countries. The average shipment value is $31.1K.

Which countries import metformin from India?

India exports metformin to 160 countries. The top importing countries are UNITED STATES (36.7%), GEORGIA (9.7%), FRANCE (4.9%), UNITED KINGDOM (4.4%), BELGIUM (3.6%), which together account for 59.3% of total export value.

What is the HS code for metformin exports from India?

The primary HS code for metformin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Metformin

Metformin

Top Metformin Exporters from India

Top Countries Importing Metformin from India

Who Supplies Metformin to India?

Quick Facts

Related Diabetes & Endocrine

Related Analysis

Need Details?

Metformin — Export Intelligence Video

Regulatory Landscape — Metformin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Metformin

Supply Chain Risk Assessment — Metformin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Metformin Trade Intelligence

Frequently Asked Questions — Metformin Exports from India

Who are the top metformin exporters from India?

What is the total export value of metformin from India?

Which countries import metformin from India?

What is the HS code for metformin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of metformin exports from India?

Which ports handle metformin exports from India?

Why is India a leading exporter of metformin?

What certifications do Indian metformin exporters need?

How many buyers import metformin from India?

What is the market share of the top metformin exporter from India?

Analysis Methodology